Abstract
Objective:
To evaluate the clinical utility of urinary β-2-microglobulin (B2M) at birth, an alternative to proinflammatory cytokines, as an indicative marker of fetal inflammatory response and subsequent higher risk of bronchopulmonary dysplasia (BPD) in premature infants.
Study Design:
The relationship between urinary B2M at birth and the occurrence of BPD was examined in 96 premature infants with a description of perinatal backgrounds. Constructing a receiver-operating characteristic curve to determine the cutoff value of urinary B2M at birth for the development of BPD, a multivariate logistic regression analysis was performed to evaluate whether elevated urinary B2M at birth can be used as a predictor of BPD.
Results:
BPD was diagnosed in 34% (33/96) of the infants. Neonates with BPD had a significantly higher occurrence rate of chorioamnionitis and greater levels of median urinary B2M at birth than did those without BPD. The selected cutoff value of urinary B2M at birth correlated with the development of BPD, even after adjusting for gestational age and other confounding factors.
Conclusions:
Elevated urinary B2M levels at birth can be used as an alternative marker of fetal inflammatory response and subsequent higher risk of BPD in premature infants.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Dudley DJ . Pre-term labor: an intra-uterine inflammatory response syndrome? J Reprod Immunol 1997; 36: 93–109.
Romero R, Gomez R, Ghezzi F, Yoon BH, Mazor M, Edwin SS et al. A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. Am J Obstet Gynecol 1998; 179: 186–193.
Yoon BH, Romero R, Park JS, Kim CJ, Kim SH, Choi JH et al. Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol 2000; 182: 675–681.
Yoon BH, Romero R, Kim KS, Park JS, Ki SH, Kim BI et al. A systemic fetal inflammatory response and the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1999; 181: 773–779.
Gomez R, Romero R, Ghezzi F, Yoon BH, Mazor M, Berry SM . The fetal inflammatory response syndrome. Am J Obstet Gynecol 1998; 179: 194–202.
Yoon BH, Romero R, Jun JK, Park KH, Ghezzi F, Kim BI . Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interluekin-1 beta, and interluekin-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1997; 177: 825–830.
Bethea M, Forman DT . 2-Microglobulin: its significance and clinical usefulness. Ann Clin Lab Sci 1990; 20: 163–168.
Kin K, Kasahara T, Itoh Y, Sakurabayashi I, Kawai T, Morita M . Beta2-microglobulin production by highly purified human T and B lymphocytes in cell culture stimulated with various mitogens. Immunology 1979; 36: 47–54.
Lifson AR, Hessol NA, Buchbinder SP, O’Malley PM, Barhart L, Segal M et al. Serum beta 2-microglobulin and prediction of progression to AIDS in HIV infection. Lancet 1992; 339: 1436–1440.
Hibi S, Ikushima S, Fujiwara F, Hashida T, Tsunamoto K, Todo S et al. Serum and urine beta-2-microglobulin in hemophagocytic syndrome. Cancer 1995; 75: 1700–1705.
Nishimaki S, Shima Y, Satoh M, An H, Hashimoto M, Nishiyama Y et al. Urinary beta2-microglobulin in premature infants with chorioamnionitis and chronic lung disease. J Pediatr 2003; 143: 120–122.
Berry SM, Lecolier B, Smith RS, Bercau G, Dombrowski MP, Puder KS et al. Predictive value of fetal serum beta2-microglobulin for neonatal renal function. Lancet 1995; 345: 1277–1278.
Nesovic-Ostojic J, Klun I, Vujanic M, Trbovich A, Djurkovic-Djakovic O . Serum beta2-microglobulin as a marker of congenital toxioplasmosis and cytomegalovirus infection in preterm neonates. Neonatology 2008; 94: 183–186.
Dreux S, Rousseau T, Gerber S, Col JY, Dommergues M, Muller F . Fetal serum beta2-microglobulin as a marker for fetal infectious disease. Prenat Diagn 2006; 26: 471–474.
Jobe AH, Bancalari E . Bronchopulmonary dysplasia. NICHD-NHLBI-ORD Workshop. Am J Respir Crit Care Med 2001; 163: 1723–1729.
Grey HM, Kubo RT, Colon SM, Poulik MD, Creswell P, Springer T et al. The small subunit of HLA antigens is β2-microglobulin. J Exp Med 1973; 138: 1608–1612.
Halloran PF, Wadgymar A, Autenrreid P . The regulation of expression of major histocompatibility complex products. Transplantation 1986; 41: 413.
Halloran PF, Autenried P, Ramassar V, Urmson J, Cockfield S . Local T cell responses induce widespread MHC expression. J Immunol 1992; 148: 3837–3846.
Tack ED, Perlman JM, Robson AM . Renal injury in sick newborn infants: a prospective evaluation using urinary beta2-microglobulin concentrations. Pediatrics 1988; 81: 432–440.
Ihara T, Ochiai H, Kitamura K, Ito M, Sakurai M, Kamiya H . Markedly elevated levels of beta2-microglobulin in urine with measles viuria in patients with measles. Clin Diagn Virol 1995; 4: 285–291.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Shima, Y., Nishimaki, S., Nakajima, M. et al. Urinary β-2-microglobulin as an alternative marker for fetal inflammatory response and development of bronchopulmonary dysplasia in premature infants. J Perinatol 31, 330–334 (2011). https://doi.org/10.1038/jp.2010.129
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jp.2010.129
Keywords
This article is cited by
-
Urinary ß2-microglobulin in very preterm neonates with chorioamnionitis
Pediatric Nephrology (2011)